It is now recognized that clinical findings may be variable. Approximately 90% of the cases have a severe fulminating ulcer diathesis, and about 50% of these are associated with severe diarrhea. Ten percent have gastric hypersecretion with severe diarrhea but without ulcer formation (7) . Fewer than 10% have a pancreatic tumor with diarrhea which is not associated with gastric hypersecretion or peptic ulceration. The diarrhea has been so severe that it has been called pancreatic cholera (8) .
Initially Zollinger and Ellison (1) proposed that the tumors in the pancreas secreted a substance that caused the gastric hypersecretion. Their theory that this substance was responsible for the peptic ulceration and the poor response to medical and surgical therapy proved to be correct. In 1960 Prof. R. A. Gregory (9) reported that pancreatic tumors found in patients with this illness contained a potent gastrin-like hormone, which was 45 times more active than an equal weight of hog antral mucosa. Despite the marked gastric volume and acid hypersecretion, investigators (10) (11) (12) have reported the successful use of anticholinergics in the treatment of this syndrome, with one possible recovery (12) and one spontaneous remission (13) .
Initially the syndrome was thought by many to be rare. However, in 1964 
CASE REPORT
When first seen in July 1958, the patient, ML, a 29-year-old female, complained of epigastric distress of 2 weeks' duration. She had first become ill in 1956 with typical ulcer symptoms. Abdominal distress was usually relieved by antacids but not always by milk or food. Approximately 2 months prior to her first hospital visit she had vomited ~ome clots of blood. This had not occurred previously. There was no family history of endocrine tumors; one brother had a peptic ulcer.
Examination revealed a tall, well developed, well nourished, Negro female with no physical abnormalities except for some epigastric tenderness on palpation.
An upper gastrointestinal X-ray in August 1958 revealed an active duodenal ulcer, 1 cm in diameter, on the posterior wall (Fig 1) .
She was treated with antacids, propantheline bromide and hland diet. To control symptoms, the close of anticholinergic medication was rapidly increased to 120 mg qid. In 3 months this (lose was reduced to 60 mg qid with good control of symptoms. As symptoms were controlled, she was less tolerant of side effects, so the dose was again decreased in July 1959 to 15 mg qid.
In March and June she was admitted for recurfence of abdominal distress. No ulcer crater was seen on X-ray. Large hourly doses of antacids did not control symptoms without large closes of an anticholinergic. A follow-up X-ray in December showed an active dnodenal nicer (Fig 1) . The patient was admitted in Ja,,m,,, 1961 for recurrent symptoms, and throughout most of 1hat year sin: had inlermittent ulcer syml)toms.
In Septemher 1961 she was sHIrled oll a new anticholinergic, heleroninm bromide (15) . Although the average dose of this drug is 1.5 nag qid, this patient's close xaried from 8 to 20 mg qid. At the maximum dose, she dmeloped tolerable blurring of vision.
Gastric analyses, all done in the morning, revealed marked hypersecretion and hyperacidity. A 1-hr basal and 3-t hr-long postdrug studies were done; the average responses are reported in Table  1 . When the 3 l-hr basal morning studies were averaged, the patient had an hourly gastric secretory output of 242 ce containing 18.4 mEq total acid. Heteronium bromide, 16 rag, given orally as one close, decreased the gastric secretory wflume by 55% and the basal acid by 39%. On the basis of the marked gastric hypersecretion and diminishing clinical response to a strict medical regimen, a tentative diagnosis of Zollinger-Eltison syndrome was made and the patient was operated upon in April 1962.
At operation the li~er appeared normal, but the uterus was enlarged, resemhling a 3-1-month pregnancy. There was some deformity in the area of the pylorus and first portion of the duodenum. A rounded mass, approximately I in. in diameter and freely movable, was felt in the proximal portion of the body of the pancreas. The tumor appeared to be fairly well encapsulated (Fig 2) . The body containing the tumor and the tail of the pancreas were removed. Careful examination of the patient during surgery revealed no other tumors in the remaining pancreas and no evidence of metastases to any of the abdmninal organs. A subdiaphragmatic vagotomy, 50% gastrectomy (Bilroth II), suhtotal pancreatectomy, and splenectomy were done.
Pathologic studies revealed that the tumor was an islet cell carcinoma of the pancreas. The cells were arranged ill a cord-like fashion, in some areas assuming a gland-like pattern, or in sheets with nuclei closely approximated to each other. Mitoses were also seen (Fig 3) . Bands of fibrous tissue extended between the cords and sheets of neoplastic cells. Neoplastic cells were encountered within a blood vessel. Other areas showed tumor cells within perineural l~mphatic vessels (Fig 4) . Sections through the remainder of the pancreas were reported as normal, and sections of the stomach, spleen and peripancreatic lymph nodes were not remark. ahle.
The patient did well during surgery, her postoperative recovery was uneventful, anti she was Gastric secretory studies were repeated 4, 7, and 27 m o n t h s postoperatively (Table 1) . Total mEq of hydrochloric acid at the 4 -m o n t h period was slightly elevated, b u t at the 7-and 27-month periods, acidity was well within n o r m a l limits. It was t h o u g h t that all of the t u m o r tissue had probably been removed.
Approximately 44 m o n t h s after surgery, the patient reported a recurrence of ulcer s y m p t o m s requiring frequent doses of antacids for relief. Repeated gastric analyses at 44-51 m o n t h s revealed that she was again secreting large quantities of gastric juice with an increased q u a n t i t y of total acid. An average of the 4 1-hr control studies revealed that she was secreting 241 ml containing 18.1 m E q / h r of total HC1. After she had received h e t e r o n i u m bromide, her gastric secretion averaged 175 ml (--27%) containing 6.9 mEq ( --6 2 % ) / h r of total HC1. A l t h o u g h there was some variation in the results obtained postoperatively, the control studies suggested that there was increasing stimulation of gastric parietal cells as time progressed.
F u r t h e r study of the patient at this time indicated a n o r m a l female with m i n i m a l to moderate epigastric tenderness. T h e previous surgical scar was well healed. T h e a b d o m e n was soft, no ma~ses were palpable, the liver was not enlarged, and there was no physical evidence of metastases. T h e thyroid was palpable and no nodules were felt. T h e PBI on two different occasions was 4.8 and 5.0 ~g/100 cc. T h e laboratory studies revealed a hemoglobin of 12.5 g, hematocrit 38%, total leukocytes 7450, BSP 1%, p r o t b r o m b i n time 100%, alkaline phospbatase 2.4 units (normal = 1-3.5 K R B ) , total bilirubin 0.8 rag%, S G O T 20 units, serum calcium 8.4 rag%, p h o s p h o r u s 3.3 rag%, fasting glucose 98 m g % and n o r m a l serum electrolytes. Urinalysis was normal and 24-hr urine amylase was 574 units.
A bone survey and scan with SR *5 were negative for metastases. A skull X-ray, EEG, and brain scan with HG ~°a were within normal limits. Gastrointestinal X-ravs on A u g 2, 1964 , and March 30, 1965. reported a n o r m a l stoma, but on July 26, 1966, a gastric and jejunal ulcer were demonstrated. Gastroscopy on Dec 15, 1965 , showed a small jejunal Fig 3 (top) . Microphotograph of typical histologic pattern of excised tumor. Cells resemble those of islets of pancreas . Fig 4 (bottom) . Microphotograph of pancreatic tumor. Note perineural lymphatic invasion by islet cells.
ulcer, and on Oct 5, 1966 , two small ulcers were seen in the jejunum. Glucose tolerance tests with 100 g of glucose were reported as shown in Table 2 .
During this period the patient was treated with regular doses of antacids with fair to good response. Because of marked gastric atony, she was not treated with anticholinergie drugs during this period of recurrence.
Ou Dec 8, 1966 , her abdomen was again carefully explored. There was no evidence of recurrence of the tumor in the pancreas or of metastases to any of the abdominal organs. A total gastrectomy was performed with interposition of a 25-cm segment of transverse colon to serve as a stomach.
A gross examination revealed no ulcers in the remaining stomach or in the jejunum. On pathologic study one section of gastric mucosa did display a loss of mucosal cells with necrosis and hemorrhage of the mucosa and lamina propria. No tumor cells were seen in sections of six omental lymph nodes.
The patient's postoperative course was uneventful. Follow-up X-rays on Jan 311, 1967, and June 1, I.1t67, showed that the transposed colon-stomach was operating satisfactorily. She did well except for some minimal symptoms of postgastrectomy dumping which were easily controlled hy diet.
Because of a low serum folic acid (746 picograms (peg) /cc; normal = 6000-21,000) , she was started on 5 nag folic acid, orally, hid. She was also given I00 txg of Vitamin B~e, parenterally, each ntonth. In September 1968, she began work as a preschool teacher. In February and Max of 11.)69 she was reported by Dr. J. E. Mc(;uigan's laborator~ to have serum gastrins of 800 and 751) f)cg/ml, respectively.
He stated that both were in the range of the Zollinger-Ellison syndrome (16). In July 1969 she was started on acetohexamide, 500 mg da. At this time she is feeling well, working daily, and has maintained her weight at approximately 135 lb since the April 1962 operation. Fasting  101  96  146  208  202  336  1  194  295  300  2  60  142  154  3  58  80  97  4 71
DISCUSSION
For patients with this syndrome, Zollin: ger and Elliott (17) recommend removal of tim tumor and total gastrectomy. They claim that over 501~, of such patients have multiple tumors, and that nearly two-thirds of the patients reported in the literature had a recurrence of symptoms alter either local removal of a tumor or subtotal gastrectomy and partial pat~createctomy. In patients with multiple tumors or in those with metastases, symptoms will recur unless the target organ, the stoInach, is removed. Although there may be exceptions, persistence of tunlor tissue usually means continnation of gastric hypersecretion. Alter our patient's initial surgery, it was believed that the entire tumor mass had been removed. No evidence of nletastases was seen, and the remainiug pancreas was normal to palpation, in retrospect, it is believed that the original ttnnor probably infiltrated the remaining pancreas, especially since there was a definite worsening of her glucose tolerance. The tmnors are known to be slow growing and apparently took ahnost 4 years to manifest themselves in this patient. During the second laparotom}, there was no gross evidence of metastases and 6 omental lymph nodes were negative. This experience suggests that patients should be followed for a ntnnber of }'ears before predictions concerning results of therapy can be made.
Jordan et al (18) do not believe that total gastrectomy is always necessary in all patients with a pancreatic tumor. They state that there is evidence to indicate that removal of the tumor may control the disease, although this patient was not cured after removal of what seemed to be the entire tumor mass in the pancreas. They suggest that initial treatment of these patients should consist of the standard surgi-cal procedures for ulcer and tumor control. If the ulcer recurs, then total gastrectomy should be performed and the patient's progress followed. In view of the long life expectancy of these patients, even when metastatic lesions are present, total gastrectomy would seem to be the procedure of choice.
Reports on the use of anticholinergic drugs for the treatment of patients with this syndrome suggest that these drugs exert a less marked effect in such patients than in those with ordinary peptic ulcer. Shay, et al (10) Shimoda and Rubin (11) and Lawrie et al (12) have reported a good clinical response to this form of treatment. In the present patient, large doses were needed initially to control symptoms. After a few months, the dosage could be reduced with continued good response. Later, as the disease proD'essed, the patient could not decrease dosage withont a prompt return of symptoms.
Makhlouf (19) , who studied the effects of gastrin and atropine in man, reported that although atropine significantly inhibited the effect of small doses of gastrin, the inhibition became insignificant as the dose of gastrin was increased. The dose-response curve for gastrin and atropine suggested that inhibition could theoretically be overcome if large enough doses of gastrin could be given.
SUMMARY
A 29-year-old female patient had severe peptic nicer disease associated with Zollinger-Ellison syndrome caused by a large islet cell carcinoma of the pancreas. She was treated successfully for 44 mouths with large doses of anticholinergic drugs. After the removal of the pancreatic tumor, a 50°~(, gastrectomy and a vagotomy, there was marked reduction of gastric secretion, and the patient remained symptom-free for 44 months. She had two successful pregnancies, one prior to and one after the tumor had been removed. At her request, further preganancies were prevented by an intrauterine contraceptive device.
When peptic ulcer symptoms and gastric hypersecretion recurred, the patient was again explored. The pancreas appeared normal and no metastatic lesions could be found. At this time she had a total gastrectomy with colonic interposition. Serum gastrin levels, assayed on two occasions, approximately 2 years later, were elevated. Almost 3 years later the patient feels well, is working daily, and maintains her weight at 135 lb.
